For abatacept plus MTX versus MTX , DAS28 ( CRP ) < 2.6 was achieved in 60.9 % versus 45.2 % ( p = 0.010 ) at 12months , and following treatment withdrawal , in 14.8 % versus 7.8 % ( p = 0.045 ) at both 12 and 18months .